MENU

CADL Candel Therapeutics Forecast, Technical & Fundamental Analysis

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

CADL is expected to report earnings to fall 42.31% to -30 cents per share on November 12

Candel Therapeutics CADL Stock Earnings Reports
Q3'26
Est.
$-0.30
Q2'26
Missed
by $0.29
Q1'26
Beat
by $0.20
Q4'25
Missed
by $0.29
Q3'25
Missed
by $0.03
The last earnings report on August 13 showed earnings per share of -51 cents, missing the estimate of -23 cents. With 231.30K shares outstanding, the current market capitalization sits at 669.54M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COKE214.286.31
+3.03%
Coca-Cola Consolidated Inc
CECO51.83-0.17
-0.33%
CECO Environmental Corp
WTBA30.66-0.15
-0.49%
West Bancorporation
LUD3.95-0.02
-0.50%
Luda Technology Group Ltd
VWAV1.27-0.08
-5.93%
Visionwave Holdings Inc

CADL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with EDIT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-1.48%
EDIT - CADL
50%
Loosely correlated
-8.91%
FDMT - CADL
48%
Loosely correlated
-0.16%
NTLA - CADL
48%
Loosely correlated
-7.76%
CRSP - CADL
47%
Loosely correlated
-9.77%
SANA - CADL
47%
Loosely correlated
-1.42%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
55
Web
https://www.candeltx.com